BioCentury
ARTICLE | Politics & Policy

China adds insurance coverage for 17 cancer therapies

October 10, 2018 9:44 PM UTC

China's National Medical Insurance Administration added 17 cancer drugs to the National Reimbursement Drug List (NRDL) for coverage by the country's medical insurance program.

The prices will go into effect by the end of October and will remain valid until Nov. 30, 2020. The list includes dosage and pricing information; according to the document, the percentage paid by insurance is determined by each local coordinating area...